Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
atezolizumab
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT02594384
2024-08-22
LAM-002A/NHL
OrphAI Therapeutics
Phase 1
Completed
62 enrolled
20 charts